INVOcell has the ability to significantly transform the way in which doctors assist infertile patients to become pregnant in a simpler, more natural and cost effective manner. The INVO Intravaginal Culture (IVC) system provides the Assisted Reproductive Clinics and Physicians around the globe with the ability to offer an additional infertility treatment to hopeful patients. FDA Cleared for use in the US, the INVOcell device and procedure is less expensive than traditional IVF with comparable efficacy and pregnancy rates. The INVO Procedure is simple so it can be easily performed in an appropriately trained physician’s office.
The patented INVOcell is used for the incubation of eggs and sperm during fertilization and early embryo development. Unlike conventional infertility treatments such as in IVF where the eggs and sperm undergo fertilization and early embryo development in a laboratory incubator, the INVOcell utilizes the women’s vagina as a natural incubator to support fertilization and embryo development. INVOcell is not a complex electromechanical device as it relies only on the in vivo environment, the natural vaginal pH, temperature and gasses, as well as the natural body movements.
The INVOcell technology offers patients a more personal approach to achieving pregnancy. It has been proven safe and effective in decreasing the side effects of stimulating drugs when used in association with mild stimulation protocols, reducing the risk of errors in transferring embryos and minimizing the chance for creating unused embryos.
For many couples struggling with infertility, access to treatment is often not available. Financial challenges, limited availability of specialized medical care, religious, social, or cultural roadblocks can prevent these hopeful parents from realizing their dream to have a baby. With the INVO Solution, more and more patients can now receive safe, effective and affordable infertility treatment.
INVOcell has been clinical tested and substantiated on 450 cycles, granting the device FDA clearance. Additionally, over 3,000 cases have been performed across the globe. The success rates for INVOcell are equivalent to traditional IVF. Moreover, the psychological benefits of direct participation with in vivo incubation and fertilization are incomparable to traditional IVF treatments. Couples participating in the treatment are more directly involved with the conception and control of the destiny of their embryo(s).
There are many features and benefits of the INVO fertility treatment. One of the greatest benefits is having a simpler procedure reducing the overhead and infrastructure costs compared to traditional IVF. This cost saving benefit can be passed to the patients, allowing more couples struggling with infertility to obtain treatment.
For more information on the INVOcell device and INVO Procedure and its efficacy, please review our clinical study and other FDA documentation in our Resources section.
View INVOcell Procedure Diagram.
How to offer the INVO Procedure at your clinic
At INVO Bioscience, our mission is to increase access to care and expand fertility treatment and patient care across the globe. By providing the INVO Procedure, you will be giving patients access to a new and more economical fertility treatment beyond the historical traditional treatments such as IUI and IVF, while still providing them with efficacy and successful patient care.
Please join us in our mission of helping more patients across the globe realize the dream of conceiving a child. Contact us by calling (978) 878.9505 x503 or emailing email@example.com and ask how to begin offering the INVOcell in your office or clinic.